Eye Diseases - Dennis Clegg, Kristin MacDonald, Henry Klassen, Theodore Leng, Sophie Deng
Stem cells may lead the way towards innovative treatments for eye disease. Hear from experts on the latest research.
Moderated by Dennis Clegg, PhD, UC Santa Barbara
Kristin MacDonald: Patient Perspective
Henry Klassen, MD, PhD, UCI: Retinal Progenitor Cells for Treatment of Retinitis Pigmentosa
Theodore Leng, MD, MS, Stanford University: NeuBright, a purified allogeneic cell therapy product for treatment of Dry Age-related Macular Degeneration